Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer - Archive ouverte HAL
Journal Articles European Journal of Cancer Year : 2016

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer

Mohamed Hebbar
Christian Focan
  • Function : Author
Salvatore Tumolo
  • Function : Author
René Adam
  • Function : Author
Francis Lévi
  • Function : Author
Fichier principal
Vignette du fichier
WRAP_flaccept_ak_optiliv_ms_er_13june2016_rev1_fl.pdf (789.2 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04545408 , version 1 (04-09-2024)

Identifiers

Cite

Mohamed Bouchahda, Valérie Boige, Denis Smith, Abdoulaye Karaboué, Michel Ducreux, et al.. Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer. European Journal of Cancer, 2016, 68, pp.163-172. ⟨10.1016/J.EJCA.2016.09.011⟩. ⟨hal-04545408⟩
29 View
5 Download

Altmetric

Share

More